Impact on Patients: A patient receiving a vial of semaglutide sodium compounded may be receiving a product with changed, likely reduced, potency
The fact that outcomes track with the number of receptors engaged and specifically that GCGR addition produces a step-change in both energy expenditure and hepatic effects provides strong mechanistic justification for the triple agonist approach beyond simply more aggressive incretin stimulation
Lalau JD, Kajbaf F, Bennis Y, Hurtel-Lemaire AS, Belpaire F, Broe MED (2018) Metformin treatment in patients with type 2 diabetes and chronic kidney disease stages 3A, 3B, or 4
1.2.2 Overview of redox homeostasis in liver physiology The liver is a key metabolic organ, responsible for detoxification, synthesis, and storage of metabolites, as well as the handling of xenobiotics
In the recent STEP HFpEF DM trial, which studied the efficacy of semaglutide among patients with obesity-related HF with preserved ejection fraction (HFpEF) and T2D, a reduction in the time to first HF events was demonstrated in the intervention arm, but this was a secondary endpoint
This is why supplementation or treatments such as glutathione injections are becoming increasingly popular for those wanting to restore their levels and reap its many benefits
